Cerevance

Discovering and developing novel therapeutics for neurological and psychiatric disorders

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups6 employees language cerevance.com

Registered entities

Innovation

17 patent families — focus: Chemistry & metallurgy; filing pace steady. Cited 1,080 times.

YearFilings
20191
20202
20212
20226
20238
20248
20258
20262

Social engagement

Social engagement: 6.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

17 investors on record; lead investors include Google Ventures, Foresite Capital, Lightstone Ventures, Takeda Ventures.

Investor typeCountShare
Venture capital1271%
Other / undisclosed529%

Recent activity

9 Apr 2026
Event
American Academy of Neurology Annual Meeting
10 Mar 2026
Event
AD/PD 2026 International Conference on Alzheimer's & Parkinson's Diseases
Coming soon